Collagenase in the Treatment of Cellulite

Stony Brook University

Status and phase: Unknown; Phase 2

Conditions: Cellulite

Treatments: Biological: Biological; Drug: Collagenase

Study type: Interventional

Funder types: Other

Identifiers

NCT00261144

Cell 101

Details and patient eligibility

About

The purpose of this study is to determine if collagenase injection will reduce or eliminate the appearance of cellulite of the thigh.

Full description

This is an open label study of collagenase injection therapy for reduction and/or elimination of cellulite of the posterolateral thighs.

Enrollment: 20 estimated patients

Sex: All

Ages: 18 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 10 x 10 cm area of cellulite of the posterolateral thigh(s)

Exclusion criteria

• any chronic, serious or uncontrolled medical condition
• inability to conform to study visits (12-15 per year)

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: Double Blind